Work

Ongoing phase I studies of ABT-263: Mitigating Bcl-XL induced thrombocytopenia with lead-in and continuous dosing

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.3505

Authors: A. W. Roberts, W. Wilson, L. Gandhi, O. A. O'Connor, C. M. Rudin, J. R. Brown, H. Xiong, Y. Chiu, S. Enschede, A. P. Krivoshik

Institutions: The Royal Melbourne Hospital, Johns Hopkins University, Dana-Farber Cancer Institute, National Cancer Institute, Columbia University

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2240679114

Cites:

Cited by: 10

Related to: 10